TREND UPDATE: Only 2 of These 11 Cannabis Stocks Have Traded Higher in September

During the last quarter, the cannabis sector has been under pressure and we have not seen the normal post-summer rally.

In prior years, the summer season has been slow for the cannabis sector and we were not surprised by the weakness we saw in August. Based on our years of analyzing the cannabis sector, we identified a sector wide trend where cannabis stocks would typically rally in September and we are surprised by the current trend.

11 Cannabis Stocks to be Aware of

Before providing an in-depth explanation on the recent trend, we have highlighted the performance 11 well-known cannabis companies so far this month (based on stock prices after the close on September 13^th) and believe our readers should be aware of this:

Stocks that Have Dropped More Than 10%

• Canopy Growth Corp. (TSX: WEED) (Nasdaq: CGC) has fallen more than 12%
• GrowGeneration Corp. (Nasdaq: GRWG) has fallen more than 11%
• Aurora Cannabis Inc. (TSX: ACB) (Nasdaq: ACB) has fallen more than 10%
• Auxly Cannabis Group Inc. (TSX: XLY) (OTC: CBWTF) has fallen more than 10%

Stocks that Have Dropped Between 5% and 10%

• Village Farms Inc. (TSX: VFF) (Nasdaq: VFF) has fallen approx. 9.4%
• Cronos Group Inc. (TSX: CRON) (NYSE: CRON) has fallen approx. 8.4%
• OrganiGram Holdings Inc. (TSX: OGI) (NYSE: OGI) has fallen approx. 7.4%
• Innovative Industrial Properties, Inc. (NYSE: IIPR) has fallen approx. 7.2%
• MediPharm Labs Corp. (TSX: LABS) (OTC: MEDIF) has fallen less than 5%

Stocks That Have Traded Higher

• Aleafia Health Inc. (TSX: AH) (OTC: ALEAF) has rallied approx. 9%
• High Tide Inc. (TSX Venture: HITI) (Nasdaq: HITI) has rallied approx. 5.5%

Where Does the Cannabis Sector Go From Here

When analyzing the performance of these 11 cannabis companies, it is easy to understand that most of the cannabis sector is trending to the downside. These declines come after most operators reported quarterly financial results and we will monitor how the sector is able to bounce back.

From analysts lowering price targets on leading cannabis companies to operators raising capital (debt and equity) at below market prices, there are a number of explanations for the sector’s weak performance in September.

We believe the cannabis sector is nearing an inflection point and expect to see more countries legalize cannabis (medical or recreational) over the next few years. We believe the biggest potential catalyst for the cannabis sector will be legalization in the United States. We are of the opinion that legal cannabis in the US is near-term event and will continue to closely follow how the sector continues to perform.

If you are interested in learning more about the performance of the cannabis sector, please send an email to support@technical420.com with the subject “Cannabis Stock Performance” to be added to our distribution list.

For the fastest access to data on the performance of the cannabis sector, sign up for our free newsletter!

Share

Tags

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Top Stories